Discovery of imidazoquinolines with toll-like receptor 7/8 independent cytokine induction

Ce Shi, Zhengming Xiong, Padmaja Chittepu, Courtney Aldrich, John R. Ohlfest, David M Ferguson

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Toll-like receptors (TLRs) are key targets in the design of immunomodulating agents for use as vaccine adjuvants and anticancer treatments. The imidazoquinolines, imiquimod and resiquimod, have been shown to activate TLR-7 and -8, which in turn induce cytokine production as part of the innate immune response. Herein, we report the synthesis and discovery of a C7-methoxycarbonyl derivative of imiquimod that stimulates cytokine production but is devoid of TLR-7/8 activity. Data are presented that shows that this analogue not only induces IL-12p40 and TNF production, similar to that of imiquimod and resiquimod, but greatly enhances the production of IL-1β, a key cytokine involved in the activation of CD4 T cells. It is further demonstrated that TLR-7/8 activation can be recovered by the addition of a C2-alkyl substituent to this newly discovered analogue. The results support the existence of an alternative mechanism of action by which imidazoquinolines can stimulate cytokine production.

Original languageEnglish (US)
Pages (from-to)501-504
Number of pages4
JournalACS Medicinal Chemistry Letters
Volume3
Issue number6
DOIs
StatePublished - May 14 2012

Fingerprint

Toll-Like Receptor 8
Toll-Like Receptor 7
imiquimod
resiquimod
Cytokines
Interleukin-12 Subunit p40
Chemical activation
Toll-Like Receptors
Interleukin-1
Innate Immunity
T-cells
Vaccines
T-Lymphocytes
Derivatives

Keywords

  • cytokine induction
  • imidazoquinolines
  • toll-like receptor 7/8

Cite this

Discovery of imidazoquinolines with toll-like receptor 7/8 independent cytokine induction. / Shi, Ce; Xiong, Zhengming; Chittepu, Padmaja; Aldrich, Courtney; Ohlfest, John R.; Ferguson, David M.

In: ACS Medicinal Chemistry Letters, Vol. 3, No. 6, 14.05.2012, p. 501-504.

Research output: Contribution to journalArticle

@article{104e5c0ebc6a439286dafc268d5bfdf7,
title = "Discovery of imidazoquinolines with toll-like receptor 7/8 independent cytokine induction",
abstract = "Toll-like receptors (TLRs) are key targets in the design of immunomodulating agents for use as vaccine adjuvants and anticancer treatments. The imidazoquinolines, imiquimod and resiquimod, have been shown to activate TLR-7 and -8, which in turn induce cytokine production as part of the innate immune response. Herein, we report the synthesis and discovery of a C7-methoxycarbonyl derivative of imiquimod that stimulates cytokine production but is devoid of TLR-7/8 activity. Data are presented that shows that this analogue not only induces IL-12p40 and TNF production, similar to that of imiquimod and resiquimod, but greatly enhances the production of IL-1β, a key cytokine involved in the activation of CD4 T cells. It is further demonstrated that TLR-7/8 activation can be recovered by the addition of a C2-alkyl substituent to this newly discovered analogue. The results support the existence of an alternative mechanism of action by which imidazoquinolines can stimulate cytokine production.",
keywords = "cytokine induction, imidazoquinolines, toll-like receptor 7/8",
author = "Ce Shi and Zhengming Xiong and Padmaja Chittepu and Courtney Aldrich and Ohlfest, {John R.} and Ferguson, {David M}",
year = "2012",
month = "5",
day = "14",
doi = "10.1021/ml300079e",
language = "English (US)",
volume = "3",
pages = "501--504",
journal = "ACS Medicinal Chemistry Letters",
issn = "1948-5875",
publisher = "American Chemical Society",
number = "6",

}

TY - JOUR

T1 - Discovery of imidazoquinolines with toll-like receptor 7/8 independent cytokine induction

AU - Shi, Ce

AU - Xiong, Zhengming

AU - Chittepu, Padmaja

AU - Aldrich, Courtney

AU - Ohlfest, John R.

AU - Ferguson, David M

PY - 2012/5/14

Y1 - 2012/5/14

N2 - Toll-like receptors (TLRs) are key targets in the design of immunomodulating agents for use as vaccine adjuvants and anticancer treatments. The imidazoquinolines, imiquimod and resiquimod, have been shown to activate TLR-7 and -8, which in turn induce cytokine production as part of the innate immune response. Herein, we report the synthesis and discovery of a C7-methoxycarbonyl derivative of imiquimod that stimulates cytokine production but is devoid of TLR-7/8 activity. Data are presented that shows that this analogue not only induces IL-12p40 and TNF production, similar to that of imiquimod and resiquimod, but greatly enhances the production of IL-1β, a key cytokine involved in the activation of CD4 T cells. It is further demonstrated that TLR-7/8 activation can be recovered by the addition of a C2-alkyl substituent to this newly discovered analogue. The results support the existence of an alternative mechanism of action by which imidazoquinolines can stimulate cytokine production.

AB - Toll-like receptors (TLRs) are key targets in the design of immunomodulating agents for use as vaccine adjuvants and anticancer treatments. The imidazoquinolines, imiquimod and resiquimod, have been shown to activate TLR-7 and -8, which in turn induce cytokine production as part of the innate immune response. Herein, we report the synthesis and discovery of a C7-methoxycarbonyl derivative of imiquimod that stimulates cytokine production but is devoid of TLR-7/8 activity. Data are presented that shows that this analogue not only induces IL-12p40 and TNF production, similar to that of imiquimod and resiquimod, but greatly enhances the production of IL-1β, a key cytokine involved in the activation of CD4 T cells. It is further demonstrated that TLR-7/8 activation can be recovered by the addition of a C2-alkyl substituent to this newly discovered analogue. The results support the existence of an alternative mechanism of action by which imidazoquinolines can stimulate cytokine production.

KW - cytokine induction

KW - imidazoquinolines

KW - toll-like receptor 7/8

UR - http://www.scopus.com/inward/record.url?scp=84862300033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862300033&partnerID=8YFLogxK

U2 - 10.1021/ml300079e

DO - 10.1021/ml300079e

M3 - Article

AN - SCOPUS:84862300033

VL - 3

SP - 501

EP - 504

JO - ACS Medicinal Chemistry Letters

JF - ACS Medicinal Chemistry Letters

SN - 1948-5875

IS - 6

ER -